BioNote
바이오노트KRX: 377740· Fiscal year 2025· bionote.co.kr ↗
Average salary
$40.4K
₩53.8M
▼ 2.7% vs 2024
Employees
334
▲ 6.7% vs 2024
Average tenure
4.8 yrs
Estimated take-home of this pay:$2.8K / monthCalculate →
Workplace
Women's pay (men = 100)65
Women among staff61.1%
Contract staff7.2%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
- 2026-11-12Preliminary earnings (consolidated)
- 2026-08-13Half-year report (2026.06)
- 2026-08-06Preliminary earnings (consolidated)
Quick read
- Average pay is 12% below the median of the companies we track.
- Average pay fell 2.7% from 2024.
- Headcount grew by 21 (6.7%) from 2024.
- Ranks #148 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 15.1% year over year.
- Revenue has grown two years in a row.
- Operating margin was 14.1% in 2025.
- Operating loss of $35.2M in 2023.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $265.3K
- Net profit per employee
- -$196.2K
- Operating margin
- 14.1%
- Net margin
- -73.9%
- ROE
- -5.8%
- Debt-to-equity
- 3.0%
- Equity ratio
- 97.1%
- Dividend per share
- $0
- Dividend yield (as disclosed)
- 3.8%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.